Implanet S.A. (EPA: ALIMP)

Market Cap	15.50M
Revenue (ttm)	7.30M
Net Income (ttm)	-6.06M
Shares Out	124.97M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,845
Average Volume	229,141
Open	0.129
Previous Close	0.129
Day's Range	0.124 - 0.129
52-Week Range	0.063 - 0.168
Beta	1.20
RSI	52.48
Earnings Date	Mar 4, 2025

About Implanet

Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martill...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Employees: 41
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIMP

Financial Performance

In 2023, Implanet's revenue was 7.45 million, a decrease of -7.24% compared to the previous year's 8.03 million. Losses were -6.68 million, 88.6% more than in 2022.